New imaging and radiation therapy for metastatic tumors
Part of Cancer clinical trials.
This trial tests a new type of imaging scan and treatment for cancers that have spread. You would first have two special scans, then you may receive a targeted radiation therapy (177Lu-FAPI-RGD) to see if it can help shrink tumors.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have cancer that has spread to other parts of your body (metastatic tumors)
- You have had or will have two PET/CT scans within two weeks, one using 68Ga-FAPI-RGD and one using 18F-FDG
- You are not pregnant or breastfeeding
- You do not have any other medical condition that could interfere with following the study rules
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug that targets tumors with a specific marker you can see on a PET scan. It is for people whose cancer has spread or come back after standard treatments, and it may help shrink tumors or slow their growth.
This trial tests a new imaging agent, [18F]FAPI-74, which might help detect certain cancers more clearly. The scan looks for a protein called fibroblast activation protein (FAP) that is often found in tumors. If you have one of the listed cancers and are about to start treatment, this study could help doctors see where the cancer is and how it responds to therapy.
This trial tests a special radioactive medicine (177Lu-CTR-FAPI) for people with advanced digestive cancers that have high FAP expression. The medicine targets a protein on cancer cells to deliver radiation directly to tumors, potentially slowing their growth.
This trial tests a new radioactive treatment (177Lu-OncoFAP-23) alone or combined with an immunotherapy (L19-IL2) for people with advanced solid tumors that have a specific protein called FAP. It's for patients whose cancer has grown despite standard therapies.
This study tests how useful a special PET/CT scan (called 68Ga-FAPI) is for people who may have or have been diagnosed with cancer. The scan may help doctors see cancer activity more clearly.
This study compares two special PET/CT scan tracers—68Ga-FAPI-LM3 and 18F-FDG—to see how well they detect cancer that shows FAP or SSTR2 signals. It may help doctors choose better imaging to find or assess certain tumors.
Hear when a new FAP- Expressing Positive Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.